Kekal sihat dan berjaya seperti Oleg Taktarov!Permulaan cerah di kalangan duta jenama InstaSpot!

Pelakon, juara kejohanan UFC 6 dan seorang wira sebenar!
Lelaki yang membuat dirinya sendiri. Lelaki yang mengikut cara kami.
Rahsia di sebalik kejayaan Taktarov adalah pergerakan berterusan ke arah matlamat.
Dedahkan semua segi bakat anda!
Cari, cuba, gagal - tetapi tidak pernah berhenti!

InstaSpot. Kisah kejayaan anda bermula di sini!

For Traders

Charts

#ALNY

#ALNY (Alnylam Pharmaceuticals Inc.). Kadar pertukaran dan carta dalam talian.

#ACB Kembali ke senarai instrumen #AMGN

Pertukaran Matawang

252.47 USD
26 Nov 2024 22:59

$-0.24
(-0.1%)

Penutupan sebelum

$250.7

Buka

$243.83

Paras Harga Tinggi

$253.35

Paras Harga Rendah

$247.95

52 minggu di paras tinggi

$253.35

52 minggu di paras rendah

$229.27

Muat turun arkib

Buka carta dalam paparan skrin penuh

Muat turun arkib

Buka carta dalam paparan skrin penuh

Alnylam Pharmaceuticals Inc. About company

Alnylam Pharmaceuticals Inc. is an American biopharmaceutical company, founded in 2002. The firm is mainly involved in the research and development of drugs for treating genetic disorders.

In 2016, Alnylam Pharmaceuticals Inc. was added to the Forbes list of the world’s 100 most innovative growth companies.

This year, the market capitalization of Alnylam Pharmaceuticals Inc. totals $17.65 billion. In 2021, it raised revenue of $844.29 million. In the first six months of 2022, the company earned as much as $224.82 million.

Alnylam Pharmaceuticals Inc.’s shares and factors shaping their value

The company has been listed on the NASDAQ exchange since 2004 under the ALNY ticker. Its share value currently totals $200-205. Over the past 12 months, ALNY has fluctuated in the range of $117 to $236.

When trading the firm’s stock, you should pay attention to the following factors:

The company has a heavy dependence on the state of the healthcare sector as a whole. Thus, new COVID outbreaks have a negative influence on its revenue growth;
The company occasionally introduces new drugs to the market, conducting clinical and laboratory trials and publishing the results beforehand;
Constantly growing revenues are the firm’s advantage;
Enough own funds to finance projects without the need to additionally issue securities.

InstaSpot – jutaan pelanggan mempercayai kami! Pilihan anda melakukan penting daripada diperkatakan!

Kekal sihat dan berjaya seperti Oleg Taktarov!Permulaan cerah di kalangan duta jenama InstaSpot!

#ALNY (Alnylam Pharmaceuticals Inc.). Kadar pertukaran dan carta dalam talian.

Pertukaran Matawang

Alnylam Pharmaceuticals Inc. About company

Alnylam Pharmaceuticals Inc.’s shares and factors shaping their value